Total Payments
$1,739
2024 Payments
$162.42
Companies
28
Transactions
92
Medicare Patients
11,993
Medicare Billing
$640,027
Payment Breakdown by Category
Food & Beverage$1,739 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,739 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $200.51 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $193.89 | 10 | $0 (2024) |
| PFIZER INC. | $190.30 | 12 | $0 (2024) |
| Lilly USA, LLC | $155.12 | 8 | $0 (2021) |
| ABBVIE INC. | $115.82 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $111.08 | 6 | $0 (2021) |
| Amgen Inc. | $105.06 | 7 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $99.43 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $86.72 | 3 | $0 (2019) |
| SANOFI PASTEUR INC. | $64.52 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $162.42 | 8 | GlaxoSmithKline, LLC. ($48.68) |
| 2023 | $323.29 | 17 | Novartis Pharmaceuticals Corporation ($65.89) |
| 2022 | $319.04 | 14 | Kowa Pharmaceuticals America, Inc. ($86.98) |
| 2021 | $267.24 | 15 | Lilly USA, LLC ($64.84) |
| 2020 | $154.31 | 8 | AstraZeneca Pharmaceuticals LP ($63.51) |
| 2019 | $207.82 | 12 | Janssen Pharmaceuticals, Inc ($47.65) |
| 2018 | $230.38 | 14 | Janssen Pharmaceuticals, Inc ($39.07) |
| 2017 | $74.09 | 4 | Horizon Pharma plc ($21.16) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 11/02/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Central Nervous System | ||||||
| 10/31/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Endocrinology | ||||||
| 09/24/2018 | PFIZER INC. | TOVIAZ (Drug), LYRICA | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 09/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2018 | GlaxoSmithKline, LLC. | FLULAVAL (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: VACCINES | ||||||
| 04/16/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 03/22/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 03/21/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.81 | General |
| 02/23/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO DEVICE | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 02/22/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.70 | General |
| 07/27/2017 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: KRYSTEXXA | ||||||
| 06/07/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/16/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,338 | 5,484 | $836,698 | $149,323 |
| 2022 | 33 | 2,347 | 4,198 | $634,113 | $96,423 |
| 2021 | 39 | 2,880 | 5,160 | $707,325 | $185,928 |
| 2020 | 45 | 3,428 | 6,338 | $659,385 | $208,352 |
Total Patients
11,993
Total Services
21,180
Medicare Billing
$640,027
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 348 | 812 | $324,800 | $28,867 | 8.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 82 | 82 | $23,780 | $23,173 | 97.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 107 | 108 | $75,600 | $13,203 | 17.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 49 | 241 | $24,100 | $9,337 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 233 | 233 | $93,200 | $8,985 | 9.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 118 | 123 | $18,450 | $8,813 | 47.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 95 | $26,600 | $5,735 | 21.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 290 | 492 | $36,900 | $5,074 | 13.8% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2023 | 169 | 280 | $22,400 | $4,932 | 22.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 30 | $27,000 | $4,802 | 17.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 223 | 286 | $20,020 | $4,708 | 23.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 49 | $19,600 | $4,351 | 22.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 255 | 316 | $23,700 | $4,136 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 311 | 648 | $3,889 | $3,789 | 97.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 40 | $16,000 | $3,571 | 22.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 233 | 372 | $11,160 | $2,353 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $13,750 | $2,237 | 16.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $11,000 | $1,434 | 13.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 136 | 178 | $6,230 | $1,344 | 21.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 18 | 140 | $3,500 | $1,188 | 33.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 48 | 259 | $5,180 | $1,088 | 21.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $3,120 | $756.36 | 24.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 36 | 36 | $1,620 | $681.12 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $981.92 | $513.91 | 52.3% |
| 80069 | Kidney function blood test panel | Office | 2023 | 41 | 57 | $1,425 | $479.67 | 33.7% |
About Dr. Satish Bankuru, M.D
Dr. Satish Bankuru, M.D is a Internal Medicine healthcare provider based in Coos Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689968943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Satish Bankuru, M.D has received a total of $1,739 in payments from pharmaceutical and medical device companies, with $162.42 received in 2024. These payments were reported across 92 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,739).
As a Medicare-enrolled provider, Bankuru has provided services to 11,993 Medicare beneficiaries, totaling 21,180 services with total Medicare billing of $640,027. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Coos Bay, OR
- Active Since 06/04/2011
- Last Updated 08/11/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689968943
Products in Payments
- ENTRESTO (Drug) $158.41
- TRELEGY ELLIPTA (Drug) $134.11
- TRULICITY (Drug) $123.93
- ELIQUIS (Drug) $102.23
- Livalo (Drug) $99.43
- VRAYLAR (Drug) $84.39
- Otezla (Drug) $63.04
- SYMBICORT (Drug) $56.82
- XARELTO (Drug) $53.72
- VAXELIS (Biological) $38.63
- MYRBETRIQ (Drug) $36.92
- LEQVIO (Drug) $35.48
- TUDORZA PRESSAIR (Drug) $33.02
- INVOKANA (Drug) $33.00
- UBRELVY (Drug) $31.57
- Repatha (Biological) $29.31
- DUPIXENT (Biological) $28.18
- CHANTIX (Drug) $27.59
- FLUZONE HIGH-DOSE (Biological) $25.89
- Vascepa (Drug) $23.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Coos Bay
Stacy Newman, Md, MD
Internal Medicine — Payments: $3,909
Internal Medicine $3,909
Carol Frank, Md, MD
Internal Medicine — Payments: $2,757
Internal Medicine $2,757
Dr. Joseph El Youssef, M.d, M.D
Internal Medicine — Payments: $1,892
Internal Medicine $1,892
Dr. Basil Pittenger, Md, MD
Internal Medicine — Payments: $744.47
Internal Medicine $744.47
Wendy Haack, D.o, D.O
Internal Medicine — Payments: $699.50
Internal Medicine $699.50
Bhavani Peddagovindu, Md, MD
Internal Medicine — Payments: $674.59
Internal Medicine $674.59